AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn’s Disease TranscriptOctober 2, 2026
Fed’s Kashkari says inflation is ‘still too high’ even after softer-than-expected PCE dataOctober 2, 2026
Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU) Finances October 1, 2026 Earnings Name Insights: Micron Know-how (MU) This fall fiscal 2026 Administration View “Micron delivered an distinctive fiscal This fall with…
Why I’m Still Holding Every Micron Share (NASDAQ:MU) Finances June 13, 2026 This text was written byObservePythia Analysis focuses on multi-bagger shares, primarily within the expertise sector. Our strategy combines monetary evaluation,…
